GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects, reported a study funded by the National Institute of Mental Health (NIMH) that was published last month ...
May 30, 2013
3
0
One of the most common antidepressants, sertraline, leads to an early reduction in anxiety symptoms, commonly found in depression, several weeks before any improvement in depressive symptoms, a UCL-led clinical trial has ...
Sep 19, 2019
1
397
Scientists at Stanford Medicine conducted a study describing a new category of depression—labeled the cognitive biotype—which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed ...
Jun 23, 2023
0
49
Long-term antidepressant use may double the risk of heart disease, finds the most comprehensive epidemiological study to date to investigate the health consequences from using the medication over ten years. The University ...
Sep 29, 2022
0
18
Scientists have worked out why common anti-depressants cause around half of users to feel emotionally "blunted." In a study published today in Neuropsychopharmacology, they show that the drugs affect reinforcement learning, ...
Jan 22, 2023
0
130
Doctors should prescribe fewer antidepressants and for shorter periods of time, because of the ongoing uncertainties about their effectiveness and the potential severity and durability of the withdrawal symptoms associated ...
Dec 20, 2021
0
92
Serotonin (5-HT), one of the primary hormones released in the human brain, has many essential functions. For instance, serotonin is known to stabilize the mood, produce feelings of well-being, regulate sleep patterns and ...
On March 5, the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made ...
Mar 25, 2019
0
40
Endless worry, irritability and insomnia are all symptoms of a possible anxiety disorder.
Mar 25, 2023
0
59
A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.
Nov 1, 2021
0
212
